HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
Titel:
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
Auteur:
Valabrega, Giorgio Capellero, Sonia Cavalloni, Giuliana Zaccarello, Gianluca Petrelli, Annalisa Migliardi, Giorgia Milani, Andrea Peraldo-Neia, Caterina Gammaitoni, Loretta Sapino, Anna Pecchioni, Carla Moggio, Aldo Giordano, Silvia Aglietta, Massimo Montemurro, Filippo